Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta‐analysis

M Chen, D Qin, SL Huang, TC Tang… - Neurogastroenterology …, 2021 - Wiley Online Library
Background Chinese herbal medicine (CHM) is gaining popularity in treating irritable bowel
syndrome (IBS). Although its efficacy was shown in recent randomized controlled trials …

[HTML][HTML] Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: a systematic review

J Shi, Y Tong, JG Shen, HX Li - World journal of gastroenterology …, 2008 - ncbi.nlm.nih.gov
AIM: To explore the efficacy and safety of herbal medicines (HM) in the treatment of irritable
bowel syndrome (IBS). METHODS: A computer-based as well as manual literature search …

[HTML][HTML] Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndrome: A systematic review and meta …

L Qin, J Qin, Q Yang, X Lv, L Huang - Medicine, 2019 - journals.lww.com
Background: There are many trials on the combination of Pinaverium bromide (PB) and
Flupentixol-melitracen (FM) in the treatment of diarrhea-type irritable bowel syndrome (IBS …

[HTML][HTML] Efficacy of different courses of acupuncture for diarrhea irritable bowel syndrome: A protocol for systematic review and meta-analysis

J Tian, T Li, J Zhao, D Li, J Sun, Z Li, R Shi - Plos one, 2023 - journals.plos.org
Irritable Bowel Syndrome (IBS) is the most common functional gastrointestinal disorder. As
one of the most common subtypes of IBS, IBS-D can impair the patients' quality of life (QOL) …

[HTML][HTML] Update in diagnosis and management of irritable bowel syndrome

TH Hung, CY Wang, HF Lee - Tzu Chi Medical Journal, 2023 - journals.lww.com
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by a
lack of structural or biochemical abnormalities. The current diagnosis of IBS is based on the …

[HTML][HTML] Evidence-based clinical practice guidelines for irritable bowel syndrome

S Fukudo, H Kaneko, H Akiho, M Inamori… - Journal of …, 2015 - Springer
New strategies for the care of irritable bowel syndrome (IBS) are developing and several
novel treatments have been globally produced. New methods of care should be customized …

Clinical Efficacy of Tongxie Yaofang on Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) Patients with Liver Depression and Spleen Deficiency

X WANG, W FU, Y SUN, A HUANG… - Chinese Journal of …, 2022 - pesquisa.bvsalud.org
ObjectiveTo explore the clinical efficacy and mechanism of Tongxie Yaofang in treating
diarrhea-predominant irritable bowel syndrome (IBS-D) patients with liver depression and …

Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome

M Camilleri - Expert opinion on pharmacotherapy, 2013 - Taylor & Francis
Introduction: Diarrhea-predominant irritable bowel syndrome (IBS-D) affects about one-third
of patients with IBS, which is observed in about 12% of people across five continents. The …

Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice

S Lucak, L Chang, A Halpert… - Therapeutic Advances in …, 2017 - journals.sagepub.com
Irritable bowel syndrome with diarrhea (IBS-D) is a common, chronic functional
gastrointestinal disorder with symptoms that can be distressing for patients and often result …

Treatment of irritable bowel syndrome by Chinese medicine: a review

G Chen, X Xie, C Peng - Chinese journal of integrative medicine, 2021 - Springer
Irritable bowel syndrome (IBS) is a common refractory disease. Chinese medicine (CM) has
remarkable efficacy and advantages on the treatment of IBS. This review summarized the …